About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The group’s basic and clinical research activity, above all, surrounds the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia, and these fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension or sleep-related breathing disorders.
The group has an experimental research laboratory and a clinical research and clinical trial unit. It is made up of professionals from different specialties (pulmonologists, biologists, nurses, laboratory technicians, physiotherapists etc.). This multidisciplinary team provides an added value to the group and guarantees the existence of the critical mass necessary to carry out scientific projects.
Our group is a node that belongs to the CIBERES network (CIBER for respiratory diseases) and also works in collaboration with groups of the highest national and international prestige.
PMID: 33150777 Journal: COPD-Journal of Chronic Obstructive Pulmonary Disease Year: 2021 Reference: Chronic Obstr Pulm Dis. 2021 Jan;8(1). doi: 10.15326/jcopdf.8.1.2020.0168. Impact factor: 2.409 Publication type: Paper in international publication Authors: Bellemare, Judith, Gaudreault, Nathalie, Valette, Kim, Belmonte, Irene, Nunez, Alexa, Miravitlles, Marc, Maltais, Francois, Bosse, Yohan et al. DOI: 10.15326/jcopdf.8.1.2020.0168
PMID: 33507847 Journal: Annals of the American Thoracic Society Year: 2021 Reference: Ann Am Thorac Soc. 2021 Aug;18(8):1316-1325. doi: 10.1513/AnnalsATS.202002-094OC. Impact factor: 6.831 Publication type: Paper in international publication Authors: Dore, Simone, Saderi, Laura, Faverio, Paola, Amati, Francesco, Corsico, Angelo G, Blasi, Francesco, Chalmers, James D, Rutherford, Robert, Fardon, Thomas C, Sibila, Oriol et al. DOI: 10.1513/AnnalsATS.202002-094OC
PMID: 33440893 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Jan 11;10(2). pii: jcm10020244. doi: 10.3390/jcm10020244. Impact factor: 4.242 Publication type: Paper in international publication Authors: Sampol, Gabriel, Lecube, Albert, Cambras, Trinitat, Romero, Odile, Diez-Noguera, Antoni et al. DOI: 10.3390/jcm10020244
PMID: 33045398 Journal: Journal of Allergy and Clinical Immunology-In Practice Year: 2021 Reference: J Allergy Clin Immunol Pract. 2021 Jan;9(1):487-489.e1. doi: 10.1016/j.jaip.2020.09.050. Epub 2020 Oct 9. Impact factor: 8.861 Publication type: Paper in international publication Authors: Munoz, Xavier, Rial, Manuel Jorge, Valverde, Marcela, Del Pozo, Victoria, Gonzalez-Barcala, Francisco Javier, Martinez-Rivera, Carlos, Curto, Elena, Quirce, Santiago, Barranco, Pilar, Dominguez-Ortega, Javier et al. DOI: 10.1016/j.jaip.2020.09.050
The EXPOSIM project will investigate the impact of environmental stressors such as pollution, noise and aeroallergens on immune-mediated diseases.
This recognition highlights both his career and the level of respiratory research in Spain.
The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.
EXIMIOUS (Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome), un projecte finançat per la Unió Europea que engloba 15 organitzacions de 7 països europeus.
EXIMIOUS té com a objectiu estudiar l’exposoma, és a dir, l’exposició a factors ambientals al llarg de la vida, per entendre la seva relació amb les malalties immunomediades, com ara les malalties autoimmunes o les al·lèrgies. Des del VHIR està liderat per la Dra. M Jesús Cruz i el seu equip de Pneumologia.
